Kyongbo Pharmaceutical Co., Ltd (KRX:214390)
South Korea flag South Korea · Delayed Price · Currency is KRW
5,030.00
+10.00 (0.20%)
Jun 24, 2026, 3:30 PM KST

Kyongbo Pharmaceutical Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
120,252137,943148,701200,579239,069256,999
Market Cap Growth
-5.63%-7.23%-25.86%-16.10%-6.98%-34.25%
Enterprise Value
253,330257,424236,571278,339290,819317,767
Last Close Price
5030.005770.006166.388261.779788.3410462.95
PE Ratio
346.14756.7032.0567.44391.54-
PS Ratio
0.450.520.620.931.221.51
PB Ratio
0.830.951.021.391.661.76
P/TBV Ratio
0.860.971.051.431.701.81
P/FCF Ratio
-----556.60
P/OCF Ratio
10.7118.50997.2141.4123.6114.30
EV/Sales Ratio
0.940.980.991.291.481.86
EV/EBITDA Ratio
11.5615.3910.3516.1421.8251.82
EV/EBIT Ratio
30.6573.1622.6350.20208.82-
EV/FCF Ratio
-----688.22
Debt / Equity Ratio
0.990.870.630.530.450.39
Debt / EBITDA Ratio
8.067.574.004.404.849.23
Debt / FCF Ratio
-----122.55
Net Debt / Equity Ratio
0.920.810.580.490.400.36
Net Debt / EBITDA Ratio
7.507.093.734.094.308.53
Net Debt / FCF Ratio
-3.35-3.48-6.80-14.56-20.86113.26
Asset Turnover
0.860.880.870.850.820.70
Inventory Turnover
1.951.891.852.402.652.27
Quick Ratio
0.440.490.440.530.610.59
Current Ratio
0.941.081.151.151.221.25
Return on Equity (ROE)
0.24%0.13%3.19%2.07%0.42%-4.97%
Return on Assets (ROA)
0.82%0.73%2.38%1.37%0.36%-1.69%
Return on Invested Capital (ROIC)
0.76%0.58%4.43%2.67%0.70%-3.34%
Return on Capital Employed (ROCE)
2.40%2.00%6.90%3.70%1.00%-4.50%
Earnings Yield
0.29%0.13%3.12%1.48%0.26%-2.92%
FCF Yield
-33.03%-24.71%-8.44%-2.42%-1.15%0.18%
Payout Ratio
344.08%655.72%25.77%40.19%195.77%-
Buyback Yield / Dilution
0.13%0.03%-0.03%-1.80%1.62%0.25%